Management of Ectopic Pregnancy in Right Fallopian Tube
The correct answer is B: Salpingotomy (or salpingectomy) of the right tube only. For this 32-year-old woman with a confirmed unruptured ectopic pregnancy in the right fallopian tube, the management should be either medical therapy with systemic methotrexate OR surgical management limited to the affected right tube—never hysterectomy, never bilateral salpingectomy, and never direct methotrexate injection into the tube. 1, 2, 3, 4, 5
Why Each Option is Correct or Incorrect
Option A: Hysterectomy - INCORRECT
- Hysterectomy has absolutely no role in the management of tubal ectopic pregnancy 2, 3
- The ectopic pregnancy is located in the fallopian tube, not the uterus 4, 5
- This would unnecessarily eliminate all future fertility in a young primagravida who achieved pregnancy through IVF 6
Option B: Salpingotomy of Right Tube - CORRECT
- This is the appropriate surgical approach for unruptured tubal ectopic pregnancy 4, 5, 7
- Laparoscopic salpingotomy (linear incision with removal of ectopic and tube conservation) is performed when the contralateral tube is healthy 7
- Alternatively, salpingectomy (complete removal of affected tube) is appropriate if the left tube is healthy 7
- Surgical success rates approach 100% for unruptured ectopic pregnancies 3
- Future fertility depends more on the condition of the contralateral (left) tube than on whether the right tube is conserved or removed 6
Option C: Salpingectomy of BOTH Tubes - INCORRECT
- Removing both tubes would eliminate all future natural fertility 6
- There is no indication to remove the unaffected contralateral tube 4, 5, 7
- This would be devastating for a patient who already required IVF to conceive 6
Option D: Direct Methotrexate Injection into Tube - INCORRECT
- The standard of care is systemic methotrexate (50 mg/m² IM), not direct injection into the fallopian tube 1, 3, 8
- Direct injection into the tube is not part of established protocols 1, 3
- While methotrexate can be injected directly into certain ectopic pregnancies in rare circumstances, this is not standard practice for tubal ectopics 7
Decision Algorithm: Medical vs. Surgical Management
Consider Medical Management (Systemic Methotrexate) If ALL Criteria Met:
- Hemodynamically stable 1, 2, 3, 4, 5
- Unruptured ectopic pregnancy 1, 3, 4, 5
- Ectopic mass ≤3.5 cm in greatest dimension 1, 3
- β-hCG levels ≤5,000 mIU/mL (preferably) 1, 2, 3
- No embryonic cardiac activity on ultrasound 1, 3
- Patient able and willing to comply with close follow-up 3
- No contraindications (alcoholism, immunodeficiency, peptic ulcer disease, active lung/liver/kidney/hematologic disease) 1, 3
Proceed Directly to Surgery If ANY of the Following:
- Hemodynamic instability or signs of rupture 1, 2, 3, 4, 5
- β-hCG >5,000 mIU/mL (significantly increases failure risk to 22-29% with rupture rates of 17-19%) 2, 3
- Ectopic mass >3.5-4 cm 1, 2, 3
- Embryonic cardiac activity visualized 1, 2, 3
- Significant hemoperitoneum (even if hemodynamically stable) 2
- Patient unable to comply with follow-up 3
- Absolute contraindications to methotrexate present 1, 3
Critical Information Missing from This Case
The question does not provide essential information needed to definitively choose between medical and surgical management:
- β-hCG level (critical for determining methotrexate eligibility) 1, 2, 3
- Size of ectopic mass (must be ≤3.5 cm for methotrexate) 1, 3
- Presence or absence of fetal cardiac activity 1, 3
- Hemodynamic stability 1, 2, 3, 4, 5
- Presence of free fluid/hemoperitoneum 2
Surgical Technique When Surgery is Chosen
Laparoscopic approach is preferred over laparotomy whenever the patient is stable 7
Choice Between Salpingotomy vs. Salpingectomy:
- Salpingotomy (tube-conserving): Performed when the contralateral left tube appears unhealthy or damaged 7
- Salpingectomy (tube removal): Performed when the contralateral left tube is healthy 7
- Future fertility outcomes are similar between both approaches 6, 7
- Future fertility depends primarily on the condition of the contralateral tube, not the treatment method 6
Special Considerations for IVF Patients
- This patient conceived through IVF, suggesting possible underlying tubal factor infertility 6
- Risk of heterotopic pregnancy (coexisting intrauterine and ectopic pregnancy) is higher with assisted reproductive technologies 9
- Ensure no intrauterine pregnancy coexists before proceeding with treatment 9
- Approximately only one-third of women with ectopic pregnancy subsequently deliver a live-born infant, regardless of treatment method 6
Common Pitfalls to Avoid
- Never perform hysterectomy for tubal ectopic pregnancy 2, 3
- Never remove the unaffected contralateral tube 4, 5, 7
- Do not use direct tubal injection of methotrexate as standard therapy—systemic IM administration is the established protocol 1, 3, 8
- Do not attempt methotrexate without confirming eligibility criteria (stable, unruptured, appropriate size/hCG/no cardiac activity) 1, 2, 3
- Methotrexate failure occurs in 3-36% of cases, with 12% requiring rehospitalization and potential rupture up to 32 days after treatment 1, 2, 3